Login
Toggle sidebar

Lint: pseudomyogenic-haemangioendothelioma

Strong List Colon Position
error

"T1: low to intermediate signal intensity"

Line 52:1 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> low'

"T2: variably high signal intensity"

Line 54:1 · When enboldening an intro, the colon should not be bold. '<strong>T2:</strong> variably'

"T2FS/STIR: variably high signal intensity"

Line 56:1 · When enboldening an intro, the colon should not be bold. '<strong>T2FS/STIR:</strong> variably'

"T1 C+ (Gd): homogeneous to a mildly heterogeneous enhancement"

Line 58:1 · When enboldening an intro, the colon should not be bold. '<strong>T1 C+ (Gd): </strong>homogeneous'
Acronyms
warning

"positivity of ERG, FOSB and keratins"

Line 11:19 · 'ERG' has no definition. Spell it out if it's unfamiliar to the audience.

"positivity of ERG, FOSB and keratins"

Line 11:24 · 'FOSB' has no definition. Spell it out if it's unfamiliar to the audience.

"FOSB gene rearrangement"

Line 14:9 · 'FOSB' has no definition. Spell it out if it's unfamiliar to the audience.

"Immunohistochemistry stains are usually positive for keratin, ERG FLI1 and FOSB. CD31 and smooth muscle actin are other markers that might be expressed. CD34 is usually negative 1-3."

Line 38:66 · 'ERG' has no definition. Spell it out if it's unfamiliar to the audience.

"Immunohistochemistry stains are usually positive for keratin, ERG FLI1 and FOSB. CD31 and smooth muscle actin are other markers that might be expressed. CD34 is usually negative 1-3."

Line 38:79 · 'FOSB' has no definition. Spell it out if it's unfamiliar to the audience.

"FOSB gene rearrangements with a fusion of the SERPINE1-FOSB or ACTB-FOSB have been demonstrated. Both gene fusions show similar clinical and pathological features, although solitary lesions seem to be more common with the ACTB-FOSB gene fusion 1,2."

Line 40:72 · 'FOSB' has no definition. Spell it out if it's unfamiliar to the audience.
Emphasis
warning

"FOSB gene rearrangements with a fusion of the SERPINE1-FOSB or ACTB-FOSB have been demonstrated. Both gene fusions show similar clinical and pathological features, although solitary lesions seem to be more common with the ACTB-FOSB gene fusion 1,2."

Line 40:4 · Italics should be used only in exceptional circumstances: '<em>FOSB</em> gene rearrangements with a fusion of the <em>SERPINE1-FOSB or ACTB-FOSB</em> have been demonstrated. Both gene fusions show similar clinical and pathological features, although solitary lesions seem to be more common with the <em>ACTB-FOSB </em>gene fusion <sup>1,2</sup><em>.</em>'
Strong
warning

"T1: low to intermediate signal intensity"

Line 52:1 · Generally, don't use bold in text: '<strong>T1:</strong>'

"T2: variably high signal intensity"

Line 54:1 · Generally, don't use bold in text: '<strong>T2:</strong>'

"T2FS/STIR: variably high signal intensity"

Line 56:1 · Generally, don't use bold in text: '<strong>T2FS/STIR:</strong>'

"T1 C+ (Gd): homogeneous to a mildly heterogeneous enhancement"

Line 58:1 · Generally, don't use bold in text: '<strong>T1 C+ (Gd): </strong>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Signal characteristics"

Line 49:1 · "Signal characteristics" is not a recognised heading for this article type.
Oxford Comma
suggestion

"positivity of ERG, FOSB and keratins"

Line 11:19 · Use the Oxford comma in 'ERG, FOSB and keratins'.

"form, location and size"

Line 66:5 · Use the Oxford comma in 'form, location and size'.

"relationship to bones, tendons and joints"

Line 69:21 · Use the Oxford comma in 'bones, tendons and joints'.

"Due to the rare occurrence, optimal management is still somewhat unclear. Treatment usually consists of wide surgical excision possibly with adjunctive chemo- and/or radiotherapy. Local recurrence or appearance of additional nodules is common and occurs in about 60% of patients with a short recurrence time interval of 1-2 years. Lymph node metastases or distant metastases to lungs, bones and soft tissues are infrequent but can occur even decades after the initial presentation 1-3."

Line 73:382 · Use the Oxford comma in 'lungs, bones and soft'.